Rare diseases are often misunderstood—and Primary Sclerosing Cholangitis (PSC) is no exception.

This Rare Disease Day, join Fortrea and patient advocate leaders to explore why early patient engagement, smarter trial design, and global collaboration are essential to improving outcomes for people living with PSC.

Hear the patient perspective on diagnostic challenges, access to clinical trials, and how patient‑centered research is reshaping the rare disease treatment landscape.